Patients with hepatitis C virus (HCV) infections that were treated with the novel protease inhibitor, boceprevir, had better virologic responses than patients treated with peginterferon and ribavirin ...

Several investigational drug trials were presented at The Liver Meeting 2011 -- the annual meeting of the American Association for the Study of Liver Diseases. Two groups reported the apparently ...

A new treatment for hepatitis C virus can reduce the effectiveness of certain HIV medications if taken together and vice versa, the FDA warned in a drug safety announcement. An interaction between the ...

Ten years ago, in 2013, two very effective treatments for the serious liver disease Hepatitis C, also called HCV, were approved by the U.S. Food and Drug Administration (FDA). The drugs sofosbuvir and ...

Healio spoke with Nancy S. Reau, MD, FAASLD, AGAF, about a study evaluating a hepatitis C retreatment regimen in patients who failed therapy with Vosevi. In the study, which was presented at The Liver ...

There are six major genotypes of HCV. [8] Genotype 1 accounts for approximately 75% of HCV infections in the United States, of which two thirds are genotype 1a and one third are genotype 1b. Genotype ...

Please provide your email address to receive an email when new articles are posted on . The risk for HCV infection in correctional settings is disproportionately higher than other settings. Scaling up ...

Patients who are treated with direct-acting antivirals to treat hepatitis C virus (HCV) are still at risk of developing hepatocellular carcinoma (HCC). The Enhanced Liver Fibrosis (ELF) score may be a ...

Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep ...

There’s a highly effective and often curative treatment for people with hepatitis C, but less than a third of insured patients get it within a year of diagnosis, according to a new study. The ...